FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000896040> ?p ?o ?g. }

• W2000896040 endingPage "7013" @default.
• W2000896040 startingPage "7007" @default.
• W2000896040 abstract "IL-2 is a natural, T cell-derived cytokine that stimulates the cytotoxic functions of T and natural killer cells. IL-2 monotherapy has been evaluated in several randomized clinical trials (RCTs) for remission maintenance in patients with acute myeloid leukemia (AML) in first complete remission (CR1), and none demonstrated a significant benefit of IL-2 monotherapy. The objective of this meta-analysis was to reliably determine IL-2 efficacy by combining all available individual patient data (IPD) from 5 RCTs (N = 905) and summary data from a sixth RCT (N = 550). Hazard ratios (HRs) were estimated using Cox regression models stratified by trial, with HR < 1 indicating treatment benefit. Combined IPD showed no benefit of IL-2 over no treatment in terms of leukemia-free survival (HR = 0.97; P = .74) or overall survival (HR = 1.08; P = .39). Analyses including the sixth RCT yielded qualitatively identical results (leukemia-free survival HR = 0.96, P = .52; overall survival HR = 1.06; P = .46). No significant heterogeneity was found between the trials. Prespecified subset analyses showed no interaction between the lack of IL-2 effect and any factor, including age, sex, baseline performance status, karyotype, AML subtype, and time from achievement of CR1 to initiation of maintenance therapy. We conclude that IL-2 alone is not an effective remission maintenance therapy for AML patients in CR1." @default.
• W2000896040 created "2016-06-24" @default.
• W2000896040 creator A5005831893 @default.
• W2000896040 creator A5007275246 @default.
• W2000896040 creator A5018786888 @default.
• W2000896040 creator A5022161221 @default.
• W2000896040 creator A5035535476 @default.
• W2000896040 creator A5052673276 @default.
• W2000896040 creator A5058825074 @default.
• W2000896040 creator A5062108544 @default.
• W2000896040 creator A5066861312 @default.
• W2000896040 creator A5066953797 @default.
• W2000896040 creator A5069208658 @default.
• W2000896040 creator A5077863801 @default.
• W2000896040 creator A5085474533 @default.
• W2000896040 creator A5085497381 @default.
• W2000896040 date "2011-06-30" @default.
• W2000896040 modified "2023-10-01" @default.
• W2000896040 title "Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia" @default.
• W2000896040 cites W1492609361 @default.
• W2000896040 cites W1707184873 @default.
• W2000896040 cites W1828347693 @default.
• W2000896040 cites W1865869715 @default.
• W2000896040 cites W1963662819 @default.
• W2000896040 cites W1965693792 @default.
• W2000896040 cites W1997307558 @default.
• W2000896040 cites W2013051826 @default.
• W2000896040 cites W2018591383 @default.
• W2000896040 cites W2021138125 @default.
• W2000896040 cites W2021317273 @default.
• W2000896040 cites W2033525557 @default.
• W2000896040 cites W2034128150 @default.
• W2000896040 cites W2040079124 @default.
• W2000896040 cites W2041458605 @default.
• W2000896040 cites W2043217953 @default.
• W2000896040 cites W2044311624 @default.
• W2000896040 cites W2045346511 @default.
• W2000896040 cites W2055379827 @default.
• W2000896040 cites W2057609424 @default.
• W2000896040 cites W2072658421 @default.
• W2000896040 cites W2077989877 @default.
• W2000896040 cites W2104709800 @default.
• W2000896040 cites W2107398329 @default.
• W2000896040 cites W2109742244 @default.
• W2000896040 cites W2110251344 @default.
• W2000896040 cites W2110816260 @default.
• W2000896040 cites W2116858301 @default.
• W2000896040 cites W2117281033 @default.
• W2000896040 cites W2121885598 @default.
• W2000896040 cites W2129003119 @default.
• W2000896040 cites W2134350774 @default.
• W2000896040 cites W2138571761 @default.
• W2000896040 cites W2151588959 @default.
• W2000896040 cites W2155349260 @default.
• W2000896040 cites W2162309072 @default.
• W2000896040 cites W2416628098 @default.
• W2000896040 cites W2418441018 @default.
• W2000896040 cites W24572863 @default.
• W2000896040 cites W2537595153 @default.
• W2000896040 cites W2558106806 @default.
• W2000896040 cites W2558737040 @default.
• W2000896040 cites W2979606671 @default.
• W2000896040 doi "https://doi.org/10.1182/blood-2011-02-337725" @default.
• W2000896040 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3539044" @default.
• W2000896040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21518931" @default.
• W2000896040 hasPublicationYear "2011" @default.
• W2000896040 type Work @default.
• W2000896040 sameAs 2000896040 @default.
• W2000896040 citedByCount "66" @default.
• W2000896040 countsByYear W20008960402012 @default.
• W2000896040 countsByYear W20008960402013 @default.
• W2000896040 countsByYear W20008960402014 @default.
• W2000896040 countsByYear W20008960402015 @default.
• W2000896040 countsByYear W20008960402016 @default.
• W2000896040 countsByYear W20008960402017 @default.
• W2000896040 countsByYear W20008960402018 @default.
• W2000896040 countsByYear W20008960402019 @default.
• W2000896040 countsByYear W20008960402020 @default.
• W2000896040 countsByYear W20008960402021 @default.
• W2000896040 countsByYear W20008960402022 @default.
• W2000896040 countsByYear W20008960402023 @default.
• W2000896040 crossrefType "journal-article" @default.
• W2000896040 hasAuthorship W2000896040A5005831893 @default.
• W2000896040 hasAuthorship W2000896040A5007275246 @default.
• W2000896040 hasAuthorship W2000896040A5018786888 @default.
• W2000896040 hasAuthorship W2000896040A5022161221 @default.
• W2000896040 hasAuthorship W2000896040A5035535476 @default.
• W2000896040 hasAuthorship W2000896040A5052673276 @default.
• W2000896040 hasAuthorship W2000896040A5058825074 @default.
• W2000896040 hasAuthorship W2000896040A5062108544 @default.
• W2000896040 hasAuthorship W2000896040A5066861312 @default.
• W2000896040 hasAuthorship W2000896040A5066953797 @default.
• W2000896040 hasAuthorship W2000896040A5069208658 @default.
• W2000896040 hasAuthorship W2000896040A5077863801 @default.
• W2000896040 hasAuthorship W2000896040A5085474533 @default.
• W2000896040 hasAuthorship W2000896040A5085497381 @default.
• W2000896040 hasBestOaLocation W20008960401 @default.
• W2000896040 hasConcept C10515644 @default.

• next